TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/27/21 19:34 | 12/27/21 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Janda Kim | CA | D | S.d | -18 | 5.88 | 0 | -3 | -50 | 3 | D | |||||||||||||||
9/28/21 17:37 | 9/27/21 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Janda Kim | CA | D | S.d | -340 | 8.02 | 0 | -42 | -93 | 3 | D | |||||||||||||||
9/14/21 17:00 | 9/13/21 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Janda Kim | CA | D | S.d | -64 | 8.04 | 0 | -8 | -73 | 3 | D | |||||||||||||||
4/15/21 18:43 | 4/12/21 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Janda Kim | CA | D | S.d | -13 | 6.97 | 0 | -2 | -39 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |